Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
AC Immune We shape the future of neurodegeneration by discovering and developing breakthrough therapies through pioneering science AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigenTM and MorphomerTM, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical … Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 2 | 170 | |
Canadian Pharmacists Association The national voice for Canadian pharmacists Our Mission To empower Canadian pharmacists by providing them with the tools and knowledge they need and to advocate for their essential role in health care. Company Overview CPhA is the national voice for Canadian pharmacists. The pharmacy profession and health care in general are changing, creating new opportunities for pharmacists to focus on providing better patient care. Since 1907 our national, non-profit organization has charted the course through many developments in pharmacy. Advocate for pharmacists as members of the health care team, Support, inform and advocate for members, and Provide evidence-based Canadian drug … Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech Technologies: Synthetic Biology | 3 | 2 | 1 | 104 | |
ALTEN Belgium ALTEN is a group of 57 000 professionals present all over the world and counts more than 88% of its employees being engineers. For 35 years, ALTEN has been working closely with its customers to develop their industrial strategy in the areas of Innovation, Research & Development and Information Systems Technologies. ALTEN is present in following business lines : - Technology Consulting and Engineering (TCE) : studies and conception of technological products for the technical divisions of customers in the industrial and telecom sectors - Network and Technological Information Systems (NTIS) : network and telecom architecture, creation of technological information … Type: SMB Activities: it services deeptech Technologies: Synthetic Biology | 1 | 1 | 1 | 698 | |
Life Sciences BC “Inspiring Minds Advancing Science” Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry. Biopharmaceuticals, Medical Devices, Medical Technologies, and Digital Health Care Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 32 | 5 | 25 | 31 | |
Crohn's and Colitis Canada | Crohn et Colite Canada We aim to cure Crohn's & colitis, & better the lives of everyone impacted by IBD. | Nous visons à guérir Crohn et colite Crohn’s and Colitis Canada is the only national, volunteer-based charity focused on finding the cures for Crohn’s disease and ulcerative colitis, the two main forms of inflammatory bowel disease (IBD), and improving the lives of children and adults affected by these diseases. We are one of the top two health charity funders of Crohn’s and colitis research in the world, investing over $150 million in research since 1974, leading to important breakthroughs in genetics, gut microbes, … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 7 | 3 | 8 | 102 | |
AGT Food and Ingredients Inc. AGT Food and Ingredients Inc. (AGT Foods), majority owned by Fairfax Financial Holdings Limited, is a Saskatchewan-based global leader in plant-based proteins and value-added processing of pulses, grains, staple foods and ingredients for export and domestic markets. Food Products, Pulses, Grains, Pulse Ingredients, and Traded Commodities Type: SMB Activities: foodtech Technologies: Synthetic Biology | 3 | 2 | 1 | 308 | |
Next Stage At Next Stage, we believe amazing things happen when you bring people together with a common purpose. We are committed to help advance surgical care so that more patients live longer, more fulfilling lives. Next Stage is a sharp company driven by sharp, dedicated people. As an affiliated company of Surgical Specialties Corporation, that has a proven track record within the field of precision surgical instrument design and manufacturing that underscores not only its high engineering standards, but also its customer-driven, collaborative values. With headquarter in São Paulo-SP, along with commercial operations in Ribeirão Preto-SP, Belo Horizonte-MG, Campo Grande-MS, and … Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 3 | |
SIOP Europe, the European Society for Paediatric Oncology (SIOPE) Striving to ensure the best possible care and outcome for all children and adolescents with cancer in Europe. The European Society for Paediatric Oncology (SIOP Europe or SIOPE), is the only pan-European organisation representing all professionals working in the field of childhood cancers. With more than 2500 members across 35 European countries, SIOPE is leading the way to ensure the best possible care and outcomes for all children and adolescents with cancer in Europe. SIOPE’s mission is to increase both the cure rate and the quality of cure for children with cancers. As such, SIOPE’s aim is to support education … Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech Technologies: Synthetic Biology | 11 | 1 | 10 | 33 | |
New England Biolabs be INSPIRED, drive DISCOVERY, stay GENUINE Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including the development of molecular diagnostics, as well as nucleic acid vaccines. … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 16 | 5 | 9 | 755 | |
SteriPack Group Contract Design & Manufacturing Services | Pharma | Medical Devices | Orthopedics SteriPack is a contract design & manufacturing organization (CDMO) serving the healthcare industry. We work with some of the best known pharmaceutical, medical device and orthopedic organizations globally, from our locations across the USA, Europe and Asia. We're known for our outstanding client service, our flexibility and our ability to innovate and tailor solutions to take products to market quickly, safely and effectively. Whether we're helping you overcome challenges at specific stages of the product journey, or supporting you right through from product concept to market reality, we're … Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology | 3 | 0 | 2 | 388 | |
The Jackson Laboratory Cancer. Diabetes. Alzheimer’s. Heart disease. JAX leads the search to cure diseases rooted in our DNA. OVERVIEW • The Jackson Laboratory is an independent, 501(c)3 nonprofit biomedical research institution founded in 1929 in Bar Harbor, Maine. • Our mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health. • We are a global team of nearly 3,000 people at 11 locations in Maine, Connecticut, California, Japan and China, and in remote locations around the world. • With a 2023 operating budget of $628M, JAX has substantial impact … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 2 | 2 | 2,197 | |
Syntara Syntara is an Australian pharmaceutical research company developing drugs for inflammatory and fibrotic diseases Syntara Limited (ASX:SNT) is a clinical stage drug development company targeting extracellular matrix dysfunction with its world-leading expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. Syntara is managing three phase 2 clinical studies in diseases of high unmet need with a further two potential phase 1c/2 studies being evaluated for 2024. Lead candidate SNT‐5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 1 | 57 | |
OpGen, Inc. Mission We harness the power of molecular microbiology to develop diagnostic solutions that will optimize the treatment of life-threatening, drug resistant infections. We seek to dramatically transform patient care to guide antibiotic therapy selection and help improve antibiotic stewardship. About Headquartered in Rockville, Maryland, OpGen (NASDAQ:OPGN) is a precision medicine company harnessing the power of molecular diagnostics to help combat infectious disease. Our innovative approaches to infectious disease diagnostics consist of highly multiplexed syndromic molecular panels to address the global threat of antimicrobial resistance (AMR), improve antibiotic stewardship, and decrease the spread of multidrug-resistant microorganisms (MDROs). Together we improve patient … Type: SMB Activities: biotech deeptech Technologies: A.I. Synthetic Biology | 6 | 0 | 2 | 48 | |
BioMelbourne Network Victorian industry association providing a focal point for connectivity and leadership across the Health Industry BioMelbourne Network’s mission is to foster the development of an advanced, innovation driven and sustainable health industry. As a for-purpose, industry led membership association, we encompass biotechnology, medical technology, pharmaceuticals and health innovation companies in the state of Victoria. We connect business, research, finance, health and government to support and promote the sector’s growth and facilitate the development and commercialisation of new drugs, devices, diagnostics and digital health technologies in Victoria. Since 2001, we have championed an environment that enables Victorian organisations to innovate, commercialise … Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 18 | 2 | 18 | 20 | |
Kazia Therapeutics Limited Kazia Therapeutics (NASDAQ: KZIA) is developing innovative treatments for cancers with significant unmet need. Kazia Therapeutics Limited (NASDAQ: KZIA) is an oncology-focused drug development company. Our lead program is paxalisib, which is being developed to treat glioblastoma (GBM), the most common and aggressive form of primary brain cancer in adults. There are few treatment options for sufferers of GBM and around 65% of sufferers do not respond to currently available treatments. The condition affects around 133,000 people globally per annum and the potential addressable market is worth more than US$1 billion. Kazia’s drug paxalisib, commenced recruitment to GBM AGILE, a … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 14 | |
Gyros Protein Technologies Leading provider of peptide synthesis and bioanalytical tools for biotherapeutics, cell & gene therapies, and vaccines Gyros Protein Technologies provides enabling peptide synthesis and immunoassay bioanalytical tools that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. With a large and growing installed base of instruments for nanoliter scale immunoassay automation (Gyrolab® xPand and Gyrolab xPloreTM), and peptide synthesis (PurePep® Chorus, Symphony® X and PurePep® Sonata®+) in the biopharmaceutical industry and related markets, the solutions from Gyros Protein Technologies accelerate discovery, development, and manufacturing of safer and more efficacious biotherapeutics, cell … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 0 | 4 | 137 | |
Aridis Pharmaceuticals Leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections Aridis Pharmaceuticals is a late-stage clinical development company leading the creation of transformative, first-in-class anti-infectives for life-threatening respiratory infections. The company’s pipeline of novel mechanism antibacterial and antivirals, sprung from its proprietary technology platforms, are designed to combat the growing public health threat of antimicrobial resistant bacteria (AMR). Monoclonal Antibody , Infectious Disease, Cell line Engineering, Inhalation therapy Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 24 | |
Anatomics Quality Surgical Solutions Anatomics is a medical technology company that has been manufacturing high-quality medical devices, prosthetics and software solutions since 1995. Based in Melbourne Australia, Anatomics manufactures high quality patient specific implants for global distribution and in-licenses novel technology for Australian and New Zealand distribution. We strive to be recognised as a trusted and innovative provider of quality surgical products. Our mission is to work in partnership with healthcare professionals and medical device companies to provide the highest quality surgical products. We are a company of experienced and dedicated team members who strive for better surgical outcomes by initiating … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 102 | |
Point of Care Diagnostics Answers when you need them POCD are changing the way healthcare is delivered by sourcing the finest quality technology and brining it to Australia and New Zealand for all medical professionals to take advantage of. We are passionate about providing specialist services in near‐patient diagnostics and in‐vitro testing - including equipment and products tailored to the requirements of our customers. We have extensive experience in the following forms of equipment and product delivery: * Supply of laboratory consumables * Supporting corporate health programs * Running state‐wide public health initiatives * Implementing national pharmacy health programs The company began operations in … Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 8 | |
Starpharma Starpharma is a global biopharmaceutical company and a world leader in the development of dendrimers. Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for respiratory viruses, DEP® drug delivery and VivaGel®. Medical Devices, Pharmaceuticals, and Dendrimer Drug Delivery Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology | 3 | 0 | 4 | 73 | |
Research Institute of Molecular Pathology (IMP) A leading basic research institute addressing fundamental questions in molecular biology. Part of Vienna BioCenter. The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, microscopy, immunology and cancer, developmental biology, chromosome biology, and computational biology. Molecular Biology, Disease Mechanisms, Computational biology, Immunology, Cell Biology, Chromosome Biology, Gene Regulation, Developmental Biology, and Microscopy Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 2 | 204 | |
Vienna BioCenter Vienna BioCenter is a leading life sciences campus in Europe, and we are hiring! Vienna BioCenter is a leading life sciences location in Europe, offering a unique combination of research, education and companies on a single campus: 2,800 employees, 1,500 students, 145 research groups, and 39 biotech companies. Over the last thirty years, the Vienna BioCenter has developed into one of the leading multi-disciplinary biomedical research centers in Europe and into the premier location for Life Sciences in Austria. Its institutions and companies are among the European leaders in their field and have been able to attract excellent scientists as … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 7 | 5 | 3 | 46 | |
g.tec medical engineering GmbH - NEVER STOP RECORDING Brain-Computer Interfaces & Neurotechnology g.tec medical engineering was founded in 1999 as a spin-off from the Technical University in Graz, Austria. Christoph Guger and Günter Edlinger developed the first commercial Brain-Computer Interface (BCI) system at this time. As a producer of state-of-the-art invasive and non-invasive BCI systems with sales and research partners worldwide, g.tec is a leader in the fields of BCI, medical devices, neurotechnology, neurorehabilitation and biosignal processing with branches in Schiedlberg and Graz (Austria), Barcelona (Spain), and New York (USA). g.tec’s BCI systems are realized by four major principles: slow waves, steady-state visual evoked potentials (SSVEP), motor imagery … Type: SMB Activities: healthtech biotech deeptech manufacturing Technologies: Affective Computing Synthetic Biology | 4 | 2 | 2 | 73 | |
Nemaura Pharma Limited Unlock the potential of your drug with our expertise in Transdermal and complex Injectable product development Nemaura Pharma is a private specialist biotech company who have developed several advanced versatile skin drug delivery systems. Our technologies have been designed with clinical needs in mind and are all minimally invasive and very cost-effective. We are strategically positioned to work with global pharmaceutical companies, as well as new biotechnology companies, to successfully bring both new and old drugs to patients in superior delivery formulations and systems. Founded in 2005 Nemaura has its headquarters and laboratory facilities in the United Kingdom at the … Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 36 | |
Celyad Oncology Developing Innovative Cell Therapies Against Cancer Celyad Oncology is a biotechnology company focused on the discovery and development of tecnhlologies and platform for chimeric antigen receptor T cell (CAR T) therapies. Celyad Oncology was founded in 2007 and is based in Mont-Saint-Guibert, Belgium and New York, NY. The Company has received funding from the Walloon Region (Belgium) to support the advancement of its CAR T cell therapy programs. For more information, please visit www.celyad.com. Immuno-Oncology, Cancer, Immnotherapy, shRNA multiplex, and CAR T-cells Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 44 | |
Draft Grupo de Comunicación Healthcare [Automatic translation follows] #BeDrafter #DraftHealthcare Communication group specialized in healthcare. More than 30 years committed to the health of brands and with a high knowledge of the environment in all therapeutic areas. We have a multidisciplinary team: doctors, chemists, pharmacists, publicists, journalists, photographers, economists, graduates in fine arts and audiovisual communication. More than 20 professionals sharing knowledge and providing global solutions in specialized communication in health and medical devices. The group is made up of three divisions that join forces to ensure a global, complete and comprehensive response. Draft Advertising: The advertising and communication agency. Draft G5: Division specialized in … Type: SMB Activities: martech healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 31 | |
Nanordica Medical First-in-class wound dressings with nanotechnology aiming to prevent clinical infection and promote wound closure. Nanordica Medical is an Estonian MedTech company. We are pioneers in advanced antibacterial nanotechnology preventing and curing topical bacterial infections. The company applied for several international patents and develops its first product, an advanced antibacterial wound dressing. A pilot clinical trial in the largest Estonian hospital showed Nanordica's wound dressing cures wounds that can not be cured with other methods and causes fewer adverse effects compared to the current leading antibacterial dressing. Our long-term goal is to be a world-wide renowned global deep tech company developing … Type: SMB Activities: healthtech deeptech nanotech manufacturing Technologies: Synthetic Biology | 1 | 0 | 0 | 11 | |
BANCO FARMACEUTICO - Fondazione ETS [Automatic translation follows] So that no one has to choose between eating or taking care of themselves Since 2000, the Fondazione Banco Farmaceutico ETS has been collecting and recovering medicines (about 1.5 million per year - both over-the-counter and prescription-only) to donate to over 1,700 charities that offer free social and health care to the needy. It does so mainly through 3 activities: DRUG COLLECTION DAY On the second Saturday of February each year, over 18,000 volunteers in more than 4,500 pharmacies that participate in the initiative invite customers to donate one or more medicines to local charities. COMPANY DONATIONS … Type: SMB Activities: cleantech greentech Technologies: Synthetic Biology | 9 | 1 | 7 | 23 | |
Victor Chang Cardiac Research Institute Finding cures for cardiovascular disease through world-class medical research. The Victor Chang Cardiac Research Institute is dedicated to finding cures for cardiovascular disease through world-class medical research. Renowned for the quality of its scientific breakthroughs, the team at the Institute is working urgently to discover better ways of diagnosing, treating and preventing the onset of heart disease. With over 200 scientists and doctors working together across 23 laboratories in NSW and WA, the Victor Chang Cardiac Research Institute has earned its place on the global stage as one of the most respected medical research facilities in the world. The Institute … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 0 | 6 | 217 | |
Palobiofarma S.L. Advancing healthcare through innovative adenosine receptor-based drugs Palobiofarma S.L. is a Spanish biopharmaceutical company dedicated to discovering and developing innovative drugs based on the modulation of adenosine receptors. Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 19 | |
Sareum Ltd Sareum Holdings (AIM:SAR) is a clinical-stage biotechnology company developing next generation kinase inhibitors for autoimmune disease and cancer. The Company is focused on developing next generation small molecules which modify the activity of the JAK kinase family and have best-in-class potential. Its lead candidate, SDC-1801, simultaneously inhibits TYK2 and JAK1. SDC-1801 is a potential treatment for a range of autoimmune diseases and has entered Phase 1a/b clinical development with an initial focus on psoriasis. Sareum has an economic interest in SRA737, a clinical-stage Chk1 inhibitor which it originally developed in collaboration with several Cancer Research UK-related organisations. SRA737 has shown … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
DelSiTech Ltd The natural solution for drug delivery DelSiTech is a drug delivery and drug development company based in Turku, Finland. DelSiTech has developed a unique proprietary technology making it a world leader in advanced biodegradable silica-based drug delivery. The technology has successfully been applied to the controlled release of small molecules, biopharmaceuticals and viral vectors with a focus on parenteral and local administration. We can work with you from early feasibility testing to clinical proof of concept; the technology can also be licensed to industry partners. With the DelSiTechTMSilica Matrix, we can create novel products, provide alternative administration opportunities, and extend … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 51 | |
Flindr Therapeutics Flindr develops first-in-class precision oncology therapies identified through the Immunogram Drug Discovery Engine Flindr Therapeutics, based in Oss in the Netherlands, is a private pre-clinical biotech company developing next-generation precision oncology treatments. The Company, previously called Immagene, was spun out of the Netherlands Cancer Institute (NKI) and Oncode Institute in 2020, by founders Prof Daniel Peeper, Prof Christian Blank and Dr Maarten Ligtenberg. Flindr is actively building a pipeline of highly promising, first-in-class precision oncology therapies identified through the ImmunoGram Drug Discovery Engine. It is backed by V-Bio Ventures, Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
GeneCode GeneCode is a private pharmaceutical development company focused on the development of disease-modifying therapeutics to combat neurodegeneration. The GDNF Mimetics platform leverages the disease-modifying properties of GDNF to small molecules with drug-like properties. R&D-wise, GeneCode has remarkably improved the properties of the identified hits, making them more active and effective, drug-like and better show their ability to combat neurodegeneration in Parkinson ́s disease (PD). Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 1 | |
PharmaMar Innovative Oncology Headquartered in Madrid, PharmaMar is a biopharmaceutical company, focused on oncology and committed to research and development which takes its inspiration from the sea to discover molecules with antitumor activity. It is a company that seeks innovative products to provide healthcare professionals with new tools to treat cancer. Its commitment to patients and to research has made it one of the world leaders in the discovery of antitumor drugs of marine origin. PharmaMar has a pipeline of drug candidates and a robust R&D oncology program. It develops and commercializes Yondelis® in Europe and has other clinical-stage programs under … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 1 | 1 | 454 | |
Stratacuity: Proven Scientific Placement Over 22 years of providing contract & permanent staffing solutions to Bostons Biotech and Pharmaceutical Industries. Stratacuity provides contract and permanent placement, managed services and payroll to top Pharmaceutical and Biopharmaceutical companies. We do it with specific expertise from Discovery to Manufacturing, handling a wide range of scientific skill sets to find your needle-in-the-haystack talent. Stratacuity understands that when companies hire better people the chances of new life-saving therapeutics being discovered and approved increase exponentially. Today, there are many firms handling biotech and pharmaceutical recruiting, but do they embrace the importance of the science their client is developing and how … Type: SMB Activities: biotech deeptech healthtech hrtech Technologies: Synthetic Biology | 2 | 0 | 2 | 42 | |
Gilbert Group Redefining treatment for lung patients 🫁 Gilbert is a spin-off of Delft University of Technology (TU Delft) and a group of companies based at the High Tech Campus in Eindhoven, The Netherlands. It’s our mission to make medical treatment easier and more effective for millions of lung patients to extend and improve lives, while reducing the burden of care on the healthcare systems. We redefine treatment for lung patients. We believe in delivering a social contribution to the well being of people in general and stimulating healthcare improvements in particular, using the ever evolving technological application possibilities created by science. … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 3 | 0 | 3 | 8 | |
Dompé We Embrace the Challenge in Science Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up. We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 26 | 2 | 23 | 940 | |
Sterling Pharma Solutions Sterling Pharma Solutions is a leading provider of API services to the pharmaceutical industry. Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with 50+ years’ experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) development and manufacturing services. Sterling believes that while science can be complex, partnerships should be simple. That’s why they have redefined the CDMO experience, marked by transparency, collaboration and trust; … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology SaaS | 4 | 0 | 2 | 888 | |
Cell Phones For Soldiers Connecting Those Who Protect Us Since 2004 Cell Phones For Soldiers is a national non-profit organization dedicated to providing cost-free communication services and emergency funding to active-duty military members and veterans. Since 2004, the charity has provided more than 400 million minutes of air time to servicemen and women deployed around the world, by recycling more than 25 million cell phones reducing the impact on landfills. Cell Phones for Soldiers’ program Helping Heroes Home, which provides emergency funding to Veterans in need, has supported more than 7,500 Veterans and their families. Please consider joining our mission by graciously donating employee … Type: SMB Activities: fintech Technologies: Synthetic Biology | 0 | 0 | 0 | 11 | |
InflaRx Controlling Inflammation - developing drugs to treat life threatening and chronic inflammatory diseases InflaRx (Nasdaq: IFRX) is a biopharmaceutical company pioneering anti-inflammatory therapeutics by applying its proprietary anti-C5a and anti-C5aR technologies to discover, develop and commercialize highly potent and specific inhibitors of the complement activation factor C5a and its receptor C5aR. C5a is a powerful inflammatory mediator involved in the progression of a wide variety of inflammatory diseases. InflaRx’s lead product candidate, vilobelimab, is a novel, intravenously delivered, first-in-class, anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical studies … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 51 | |
Samplix Reveal cell function with single-cell resolution. Samplix offers a cutting-edge droplet-based instrument for single-cell analysis in immunotherapy research. Our double emulsion technology enables seamless analysis and sorting on flow cytometers. Empower your research today! Xdrop encapsulates living cells and reactive molecules in highly stable double-emulsion droplets that act as microenvironments for rapid cell–cell and cell–molecule interactions during incubation. The droplets are suitable for flow cytometry and sorting. Xdrop Sort can both generate and sort double-emulsion droplets in a user-friendly workflow that does not require any experience with fluorescence-based cell sorters. The limited volume forces fast interactions and causes secreted substances … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 38 | |
Medical Device Guru LLC Medical Devices & Digital Health Consultant | Strategy, Commercialization, & Leadership | Serving Startups & Investors Medical Devices and Digital Health Consultant | Strategy, Commercialization, and Leadership Expert | Serving Startups, Investors, and Entrepreneurial Support Organizations If you have a medical technology invention or idea and need to know where to start, have launched into the marketplace and aren’t hitting your targets, or are most anywhere in between, you’ve come to the right place for expert medical device and digital health help. Whether it’s strategic direction, commercialization, fractional leadership or independent board representation, Medical Device Guru, LLC can help you … Type: SMB Activities: deeptech healthtech constructiontech Technologies: Synthetic Biology | 15 | 0 | 15 | 1 | |
Valtronic Your full-service medical device contract manufacturer Valtronic is a global medical device contract manufacturer with 40 years of experience. We provide expertise in microelectronic assemblies, electronics for active implantable medical devices (AIMDs) and complex box builds. Headquartered in Switzerland, our company spreads over three continents with design, development, industrialization and manufacturing sites in Switzerland, the United States and Morocco and employs more than 350 employees worldwide. Valtronic has locations worldwide: Switzerland Route de Bonport 2 1343 Les Charbonnieres 41-21-841-01-11 USA 29200 Fountain Pkwy., Solon, Ohio 44139 440-349-1239 Morocco Zone Industrial, Lot Number 11, 26100 Berrechid 212-522-337-779 miniaturized electronics, electronics for … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 205 | |
CIDP - Centre International de Développement Pharmaceutique Naturally Innovative CIDP, Naturally Innovative Established in 2004, CIDP is a private and independent Contract Research Organisation (CRO) that carries out high-performance R&D activities. With over 17 years of experience in the clinical research, CIDP has a strong foothold on each continent with centres located in Brazil, India, Mauritius, and Romania offering an ideal platform for all your research projects worldwide. The services provided by CIDP are segmented into five main areas of expertise: Research & Development activities, Preclinical in vitro testing, Clinical research, Biostatistics and Data Management and Regulatory Affairs. CIDP comprises a team of 130 staff members: doctors, … Type: SMB Activities: deeptech Technologies: Data Analytics Synthetic Biology | 1 | 0 | 1 | 125 | |
Pharmaron Premier life science service provider Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 20,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China. Services: * … Type: Large company Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 1 | 1,819 | |
Orchard Therapeutics - U.S. Dedicated to transforming the lives of patients with severe and other genetic diseases through innovative gene therapy. Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on ending the devastation caused by genetic and other severe diseases by discovering, developing, and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy. In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease with a single treatment. Founded in 2015, Orchard’s roots go … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 | 0 | 208 | |
Revance Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that elevate patient and physician experiences. Botulinum Toxin, biotechnology, biotech, healthcare, pharmaceuticals, science, research, financial services, and fintech Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 4 | 1 | 2 | 639 | |
MIP Discovery nanoMIPs - synthetic antibodies with robust characteristics and secure supply Our proprietary technology includes a novel method to make nanoMIPs which circumvents the drawbacks of traditional MIP manufacturing methods. NanoMIPS are, as the name suggests, nanostructured polymer particles typically containing a single binding site for their target. They can also be fused to solid substrates, such as sensor surfaces, if required. The robust nature of MIPs and nanoMIPs make them ideal reagents for a wide range of applications including point-of-care diagnostics and in field based testing. As they are synthetic polymers, MIPs can withstand harsh chemical environments such as extremes … Type: Startup Activities: deeptech biotech manufacturing Technologies: Synthetic Biology | 1 | 0 | 0 | 15 | |
LPG® UK World leader in cellular stimulation with its technologies for Health, Beauty and Wellness. LPG® UK is the UK subsidiary of LPG® Group. World leader in cellular stimulation, LPG® Group is a French company set-up in 1986, that designs and commercialises in more than 100 countries non-aggressive and non-invasive treatment solutions for body and face, addressed to healthcare and beauty professionals, as well as the general public. endermologie® treatments are at the heart of the LPG® Group flagship products and in particular the CELLU M6 Alliance®, which reactivates cells through mechanical massage, for medical (scars, lymphatic drainage, oedema, burns etc.) and … Type: SMB Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 455 | |
Therapeutic Peptides, Inc. Therapeutic Peptides, Inc. is a research company based out of 11725Sun Belt Ct, Baton Rouge, Louisiana, United States. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 1 | |
BetaGlue Therapeutics Precision Radiotherapy From Within BetaGlue Therapeutics is a clinical stage oncology company that has developed an advanced radiotherapy platform enabling localised targeted treatment of both unresectable solid tumours and also treatment of surgical resection margins called YntraDose. radiotherapy, nuclear medicine, oncology, and medical devices Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 16 | |
NewAmsterdam Pharma Corporation NewAmsterdam Pharma Corporation is a clinical-stage biopharma company creating therapies for cardiometabolic diseases. This page is intended for US audiences. Founded in 2019, NewAmsterdam Pharma Corporation is a late-stage clinical biopharmaceutical company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies have been unsuccessful or are not tolerated. The Company is investigating a selective cholesteryl ester transfer protein (CETP) inhibitor as an LDL-C lowering therapy for patients who cannot be treated optimally with currently available lipid-lowering therapy or for patients with Atherosclerotic Cardiovascular Disease/Familial Hypercholesterolemia … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 46 | |
Biofrontera Group We aim to protect and heal your skin with our innovative photodynamic therapy medication. Biofrontera AG is a biopharmaceutical company specializing in the development and sale of dermatological drugs and medical cosmetics. The Germany-based company develops and markets innovative products for the care, protection and treatment of the skin. The company’s lead product is the combination of Ameluz®, a topical prescription drug, and medical device BF-RhodoLED® for the photodynamic therapy of certain superficial skin cancers and their precursors. Ameluz® has been marketed in the EU since 2012 and in the United States since May 2016. In the EU, the company … Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 86 | |
ADVANZ PHARMA Partner of choice in specialty, hospital, and rare disease medicines Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more … Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 643 | |
Potomac Photonics Leader in Micro Manufacturing Technologies. We enable our customers to develop products from prototyping to production Potomac Photonics, a leader microfabrication, has an extensive history of helping its clients develop miniature products and bring them to market. Utilizing cutting-edge manufacturing technology, Potomac has been recognized by both commercial and government agencies for innovative contributions to areas such as medical device manufacturing and electronics fabrication. Potomac’s high-tech facility, located in Lanham, MD, is ISO 9001:2008 and ISO 13485:2003 certified. manufacturing, micro manufacturing, and microfabrication Type: SMB Activities: deeptech manufacturing nanotech Technologies: Synthetic Biology | 16 | 0 | 13 | 27 | |
Mainstay Medical First and Only FDA Approved Restorative Therapy for Chronic Mechanical Low Back Pain Mainstay Medical, led by a team of dedicated scientists, executives, engineers, and clinical experts, brings to you ReActiv8®, the first and only FDA-approved restorative treatment for mechanical chronic low back pain. RESTORE Control RESTORE Function RESTORE Stability ReActiv8 LIFE The Company was incorporated in Dublin, Ireland and headquartered in San Diego, CA. It has subsidiaries operating in Ireland, the United States, Australia, Germany and the Netherlands. Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 136 | |
Fieldwork Your qualitative research support system. Focus on the research. We'll do the rest. Fieldwork is a qualitative research partner. We recruit respondents according to client specifications and host in-person, remote, or hybrid research sessions where clients uncover insights for brand and business impact. We coordinate logistics and provide customized global project management. Whether in our state-of-the-art facilities or online, we match the desired experience to the study requirements. Focus on the research. We’ll do the rest. Localized Recruiting , Global Field Management, Online Research, Creative Space, Focus Group Studios, Ethnographic Research , Usability Testing, Medical Recruiting, Human Factors Testing, Jury … Type: SMB Activities: martech Technologies: Synthetic Biology | 1 | 1 | 0 | 313 | |
Farmabios We supply the world with active pharmaceutical ingredients. As part of the PharmaZell Group, Farmabios is the leading global manufacturer of non-sterile and sterile steroids and offers custom development and manufacturing services of focused portfolio of High Potent Substances (HPS) and anticancer drugs. With decades of steroid chemistry expertise and ongoing research and development activities, Farmabios provides a flexible approach that meets the specific requirements of each customer. Steroids Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 0 | 93 | |
住友ファーマ [Automatic translation follows] Manufacture and sale of medical drugs, etc. Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 194 | |
Agatha Inc. We help life sciences companies manage clinical, quality, and regulatory processes so they can focus on improving lives With offices in the US, Europe, Japan and Japan, Agatha is dedicated to helping the world’s Hospitals, biotechnology, pharmaceutical, contract research organizations and medical device firms optimize the management of their Quality, Regulatory and Clinical documentation and processes. With lower costs and faster on-boarding, Agatha delivers the best ROI on business applications for life sciences that are ready to use and easy to adopt. Agatha, Inc. is a strategic software solution provider to the healthcare and life sciences industry, providing SaaS-based business … Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 1 | 1 | 44 | |
Advanced Instruments, LLC Our focus on service, quality, and reliability has made Advanced Instruments a leading developer and manufacturer of analytical instruments and services for the biopharmaceutical, clinical, and food & beverage industries for more than 65 years. Globally, we provide innovative technologies aligned with the needs of the markets we serve, helping to improve efficiency, enhance productivity, and ensure best-in-class performance. Our Solentim portfolio of best-in-class imaging and single-cell deposition technologies enables the clonal isolation, outgrowth, and characterization of the highest value cells for monoclonal antibody upstream development and cell and gene therapy. Our robust line of micro-osmometers is built specifically for … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 0 | 1 | 480 | |
ab medica spa [Automatic translation follows] about people about health Before being a company, we are people serving people. Founded in 1984, ab medica is now the leading Italian company in the production and distribution of medical technologies and wearable medical devices, as well as a point of reference for #roboticsurgery and #telemedicine. The ab medica Group includes A TLC (a leading company in the global telecommunications market), Medical Labs (production of medical devices for minimally invasive surgery), Pacinotti (distribution of medical devices) and ab salud (distribution of medical devices in Spain). The international network includes ab medica sas (France), ab medica sagl … Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 417 | |
Noveome Biotherapeutics, Inc. Transforming the way challenging diseases and conditions are treated. Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues. The company, originally founded as Stemnion, Inc., is located in the heart of Pittsburgh near the Southside Works. Noveome is passionate about growing its business in Allegheny County and helping the region to become a world leader in biotherapeutic research and development. Noveome Biotherapeutics, Inc. is a dynamic biopharmaceutical company with an innovative platform technology that represents a paradigm shift in drug development. Unlike most drugs that are single molecules … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 24 | |
BIONEEDS INDIA PRIVATE LIMITED BIONEEDS INDIA PRIVATE LIMITED is a Bangalore based Contract Research Organization providing Integrated Discovery, Development and Regulatory Services to Pharmaceutical, Biopharmaceutical, Agrochemical, Industrial chemical, Herbal/Nutraceutical and Medical device companies. Accreditation/Certifications • National GLP Compliance Monitoring Authority (NGCMA), Dept. of Science and Technology, Government of India • Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Ministry of Environment, Forests and Climate Change, GOI. • State Drug Controller as a Government approved Drug Testing Laboratory for carrying out tests on Drugs / Cosmetics and • Raw Materials used in their manufacture on behalf of licensees for manufacture … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 293 | |
Labfit - HPRD Lda Bringing excellence in pharmaceutics to you. LABFIT is a specialized company rendering services of excellence in quality control and product characterization as well as R&D of pharmaceutical products. LABFIT provides a wide range of in vitro and ex vitro services which are continuously and thoroughly implemented to meet the needs of its customers. Labfit’s portfolio includes companies from several industries such as pharmaceutical, cosmetics, chemical, biocides, biomaterials, textile, and footwear among others, which consider our company to have an interesting offer of solutions in pharmaceutical technology, namely microbiology, chemical characterization, toxicology and certification of cosmetics. Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 19 | |
Microsynth AG The Swiss DNA Company. Leading European company in nucleic acid synthesis, analysis and contract research. Microsynth (founded in 1989) is a leading company in Europe in the field of DNA/RNA syntheses & analyses. The main activities are divided into the following three business areas: 1. DNA/RNA SYNTHESES ›DNA/RNA oligonucleotides (unmodified, modified, various purity grades) for various R&D applications › Primers and probes (e.g. OEM kit production) for molecular diagnostics › antisense oligonucleotides as well as siRNAs for drug discovery 2. DNA/RNA ANALYSES AND SEQUENCING › DNA Sanger sequencing of all types (incl. GMP sequencing) › Next generation sequencing (de novo … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 70 | |
Terumo Europe Advancing Healthcare and Enhancing Patients’ Quality of Life Terumo Europe is a core player in the EMEA healthcare market by providing best-in-class quality medical products and services. We are a strong actor of the Terumo Group by contributing to innovation and sustainable growth. Terumo Europe produces, distributes, markets, and sells a vast range of medical devices in five main business units: Interventional Systems, Pharmaceutical Solutions, Hospital Care Solutions, Cardiovascular and Life Care Solutions. Our headquarters are located in Leuven (Belgium). Terumo Europe committed to cultivating a globally diverse, equitable and inclusive culture. We empower everyone to bring their authentic self … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 858 | |
BioCardia, Inc. a leader in the development of comprehensive solutions for cardiovascular regenerative therapies We are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. BioCardia is developing proprietary comprehensive biotherapeutic solutions for cardiovascular disease in its CardiAMPTM and CardiALLOTM therapies. Clinical results supporting both therapeutic programs are compelling and build upon the most rigorous data in the field to date with intramyocardial delivery of marrow-derived cells. These programs are enabled by the Company's HelixTM transendocardial delivery systems and Morph® vascular access products, which are partnered to enable other promising biotherapeutic programs. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 23 | |
EUDRAC European specialised regulatory affairs and pharmacovigilance consultancy company EUDRAC is a European specialised regulatory affairs and pharmacovigilance consultancy company providing support to our clients to drive products through development, registration, market launch and post-approval activities across all EU countries. EUDRAC is based in Germany, France, Switzerland and the UK, successfully guiding pharmaceutical and medical device companies since 2002. Our expertise covers a wide spectrum of therapeutic areas and pharmaceutical forms. Our experienced staff (majority have more than 10 years of experience) includes pharmacists, chemists, biologists, a medical doctor, and pharmacovigilance and regulatory affairs specialists. A high level of repeat business … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 1 | 1 | 0 | 22 | |
Medigene AG Living Immunotherapies Medigene AG (FSE: MDG1) is a leading immuno-oncology platform company dedicated to developing T-cell therapies to effectively eliminate cancer. Its end-to-end technology platform is built on multiple proprietary exclusive product development and product enhancement technologies, and allows Medigene to create best-in-class differentiated, T cell receptor engineered T cell (TCR-T) therapies for multiple solid tumor indications that are optimized for both safety and efficacy. This platform provides product candidates for both its in-house therapeutics pipeline and partnering. For more information, please visit www.medigene.com Immunotherapies and T Cell receptors TCR Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 106 | |
MEDICA S.p.A. Seamless innovation for life quality Medica is a human size multinational company designing and manufacturing a wide range of medical devices. Our headquarters are located in Medolla (Italy) at the heart of the largest European centre for developing and manufacturing of medical devices. Medica started its activity in the ‘80s providing R&D, prototyping and manufacturing solutions to leading companies worldwide in the biomedical sector. In the mid-’90s, Medica developed its own hollow fibre polysulfone synthetic membrane becoming the only Italian manufacturer producing hollow fibre technology membranes used for medical and water purification purposes. Nowadays, Medica manufactures and markets a complete … Type: SMB Activities: deeptech manufacturing healthtech Technologies: Synthetic Biology | 2 | 0 | 1 | 109 | |
Adaptimmune Designing and delivering cell therapies to transform the lives of people with cancer. Adaptimmune is a fully integrated cell therapy company, designed and built from the ground up with four U.K.- and U.S.-based biotechnology hub locations. Our comprehensive capabilities and teams include preclinical research, clinical development, translational sciences, autologous and allogeneic manufacturing, and in-house commercial and corporate operations. For more information about Adaptimmune, please visit www.adaptimmune.com. If interested in joining our fast growing team, click on the careers tab of this page. Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 531 | |
Phase Holographic Imaging Discover the full story of your cells. Live cell analysis now is cell-friendly, automatic & right inside the incubator. Our HoloMonitor® Live Cell Analysis tool enables label-free and kinetic live-cell imaging studies affordable for any cell lab. With novel digital holography technology, you get high-quality images and quantitative real-time data and our multiple automatic live cell assays let you easily study cell culture behavior down to single-cell level directly inside your standard incubator. Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 16 | |
Bumble Bee Foods The Bumble Bee Seafood Company is on a mission to create a new generation of seafood lovers. The Bumble Bee Seafood Company is passionately pursuing its purpose of feeding people’s lives through the power of the ocean. The iconic 120-year-old fishing company consistently aims to deliver delicious, healthy and affordable food to consumers while working hard to find new ways to protect the ocean and those that rely on it. Bumble Bee is firmly anchored in a commitment to connect the world to the ocean by re-defining sourcing, producing and enjoying products from and inspired by the ocean. Bumble Bee’s … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 2 | 2 | 320 | |
Invenio THINK. MAKE. PROTECT. Founded by healthcare industry professionals with decades of global surgical product experience, Invenio provides a full range of services and solutions for assisting in infection prevention and control. Our vast portfolio of products and capabilities allows us to work with our clientele to tailor products and programs that meet their exacting requirements. Whether the needs are for procedure packs and components, minor kits, or packaging services, our vertically integrated manufacturing provides options for on-shore, near-shore, and far shore to support supply chain resiliency and compliance requirements. Our years of clinical expertise will assist us with selecting the … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 28 | |
Amgen Deutschland [Automatic translation follows] Our mission: Help patients. We use biotechnology to treat serious diseases. Amgen was founded in 1980 and is now a leading global independent biotechnology company with around 27,000 employees in almost 100 countries. As a pioneer in biotechnology, we at Amgen have over four decades of experience in the research, development and production of innovative human therapeutics. We focus on diseases for which there are few or no treatment options. Millions of patients with serious illnesses worldwide benefit from our therapies every year. Our medicines are used in nephrology, cardiology, hematology, oncology, bone health and chronic inflammatory … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 9 | 1 | 6 | 74 | |
Bulk Pharmaceuticals Task Force An industry trade organization for manufacturers of active pharmaceutical ingredients, intermediates and excipients. The Bulk Pharmaceuticals Task Force (BPTF) is an industry trade organization representing manufacturers of active pharmaceutical ingredients, intermediates and excipients. BPTF addresses regulatory and plant operations issues related to current Good Manufacturing Practices compliance. BPTF establishes sound working relationships with regulators, allied industries and the public and serves as a reliable source for the development and implementation of balanced regulations and industry guidance resources. BPTF undertakes this advocacy on behalf of its member companies to achieve drug product and drug substance supply chain safety for consumers. Type: SMB Activities: deeptech biotech manufacturing Technologies: Synthetic Biology | 4 | 0 | 4 | 2 | |
Avadel Pharmaceuticals PLC Avadel (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. We are disrupting paradigms where it’s needed most – starting with narcolepsy. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. At Avadel, our core values foster an atmosphere of transformation and collaboration. In everything we do, we consider the patient experience, listening to their needs as we pursue the development and delivery of medicines that will transform the treatment landscape and have the greatest impact on people living with sleep disorders. Learn more … Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 3 | 0 | 2 | 192 | |
Don Whitley Scientific Ltd The leading international supplier to the microbiology and tissue culture industries Don Whitley Scientific is a leading international supplier of innovative equipment and services to the microbiology and tissue culture industries. We develop, manufacture, market and service instrumentation and associated products for the public and private sector - primarily for use in hospitals, public health laboratories, food testing organisations and research institutions. We now have the largest, most comprehensive range of workstations specifically designed for the study of anaerobes and microaerophiles. Automated microbiology and cell culture equipment, Contract microbiology laboratory, and Service and maintenance contracts Type: SMB Activities: deeptech biotech manufacturing Technologies: Synthetic Biology | 2 | 0 | 1 | 53 | |
Codexis, Inc. We deliver exquisite enzymes for the betterment of human health. Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 0 | 9 | 246 | |
Blatchford "Creating the future of mobility to realise dreams" #MobilityMadePossible We are a multi-award winning manufacturer of some of the world's most advanced prosthetic technology, bespoke seating solutions and orthotic devices. We combine clinical expertise and pioneering innovation to redefine mobility. Our evidence-based approach and commitment to continuously challenging possibilities ensures our mobility solutions prioritise the health and long-term health of our users. Through science, technology, and a clear focus on people, we make mobility possible. Lower limb prosthetic products, Prosthetic Service, Orthotic Service, Special Seating, Private Clinic, Clinical Studies, Carbon Fibre Technology, Microprocessor Technology, Medical Devices, Medical Technology, Specialist Rehabilitation, … Type: SMB Activities: healthtech deeptech transporttech manufacturing Technologies: Synthetic Biology | 4 | 1 | 3 | 485 | |
ARC GROUP UK ARC Medical // ARC Rail Training // ARC Plant and Civils Training Experienced, established, trusted and proven... We are specialists in Rail Training, Plant & Civils Training, Health Safety Training and also Medicals and Drug & Alcohol Screenings. ARC has grown into a group of four companies, recognised largely as a leading Training Provider with training centres in South Wales and London. From our early beginnings as a dedicated Rail Training provider, we have evolved into a multi-faceted, national provider of: - Rail Training - Rail Apprentices - Medicals and Drug & Alcohol Screening - Occupational Health & Safety Training … Type: SMB Activities: edtech Technologies: Synthetic Biology | 0 | 0 | 0 | 40 | |
CENTOGENE The essential biodata life science partner for rare and neurodegenerative diseases CENTOGENE’s mission is to provide data-driven, life-changing answers to patients, physicians, and pharma companies for rare and neurodegenerative diseases. We integrate multiomic technologies with the CENTOGENE Biodatabank – providing dimensional analysis to guide the next generation of precision medicine. Our unique approach enables rapid and reliable diagnosis for patients, supports a more precise physician understanding of disease states, and accelerates and de-risks targeted pharma drug discovery, development, and commercialization. Biochemical diagnostic test, Genetic diagnostic test, Rare diseases, Congenital diseases, Oncogenetics, Clinical and medical interpretation of genetic data, Next Generation … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 25 | 0 | 22 | 435 | |
ACM Global Laboratories Delivering state-of-the-art central lab services across the globe ACM Global Laboratories, an affiliate of Rochester Regional Health in Rochester, New York, is a recognized leader global clinical trial testing services. ACM Global Laboratories operates in more than 65 countries around the globe, with wholly owned facilities in the U.S.A., England, India, and Singapore. Our full-time staff of laboratory experts performs more than 20 million tests annually, spanning all medical disciplines including pathology, microbiology, molecular diagnostics, toxicology and more. For more information, visit www.ACMGlobalLab.com or call 1-866-405 0400 Central Laboratory Testing for Global Clinical Trials, Central Laboratory Services, Clinical Trials Testing, … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 446 | |
FinVector Oy Discover a unique cGMP, in a unique setting, in a unique country. Welcome to FinVector, Kuopio, Finland. Welcome to FinVector, a leading cGMP manufacturer of viral-based products with a strong commitment to restoring hope, purpose and a true sense of belonging for those living with chronic health conditions. FinVector is owned by Ferring Ventures S/A. Learn more: www.finvector.com Instagram: @finvectorians - https://www.instagram.com/finvectorians/ LinkedIn: FinVector Oy - https://www.linkedin.com/company/finvector/ GMP, Manufacturing, Biopharmaceuticals, Gene therapy, and Virus production Type: SMB Activities: deeptech manufacturing Technologies: Synthetic Biology | 1 | 0 | 1 | 332 | |
Selexis SA Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 1 | 0 | 32 | |
Plexus Ventures LLC Plexus Ventures is a prominent healthcare advisory boutique. Our team of professionals are located in markets all over the world – the United States, Europe, and the Asia-Pacific market, including China and Japan – enabling us to combine local knowledge with global reach. pharmaceutical, drug delivery, biotechnology, consumer & OTC, business development & consulting, out-licensing, in-licensing, divestments, acquisitions, global pharmaceutical market experts, marketing & sales, project management, biosimilars, medical device, and consultants Type: SMB Activities: healthtech Technologies: Synthetic Biology | 38 | 0 | 38 | 17 | |
Lockwood Lockwood collaborates with clients in the pharmaceutical, biotech, and medical device industries to identify effective, holistic, science-based strategies to address their objectives through medical and market access communications. Our clients count on us to challenge their assumptions, and help them creatively navigate around obstacles. From strategy through execution, we focus on accuracy, transparency, and scientific value to create programs that are evidence-based, clinically relevant, and contribute to the development of our clients’ brands. Over a third of our staff hold advanced scientific or medical degrees, and most work from where they live. Because our flexible structure provides better work-life balance, … Type: SMB Activities: biotech healthtech Technologies: Synthetic Biology | 3 | 0 | 2 | 400 | |
Paratek Pharmaceuticals Developing transformative solutions for patients with infectious diseases and other difficult to treat conditions Positive outcomes. Positive patient stories. These are our priorities at Paratek Pharmaceuticals. As a commercial-stage biopharmaceutical company, we develop transformative solutions for patients with infectious diseases and other difficult to treat conditions, and we believe that we have the right people, the right knowledge and the right drug to make a difference in patients’ lives. Our Mission To create positive stories for patients, physicians and caregivers based on trust and integrity. To accomplish this, our employees work hard to turn everyday decisions into everyday triumphs that … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 6 | 0 | 6 | 326 | |
mAbxience From lab to life mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 2 | 3 | 968 | |
UroGen Pharma UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results. Our existing technology: the RTGel drug delivery technology has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment. Our promising pipeline: Ranging from … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 226 | |
Genovis We help Scientist build knowledge about their Biopharmaceuticals with our SmartEnzymes Genovis offers a unique range of rapid and easy to use enzymatic tools primarily for the biopharmaceutical industry. Available worldwide, these SmartEnzymesTM are supplied in innovative formats for the development, production and quality control of biological drugs such as monoclonal antibodies, ADCs, biosimilars and bispecifics. The Genovis SmartEnzymes are widely used for the digestion, de-glycosylation and conjugation of the target molecule and are an ideal companion to popular analytical techniques like LC-MS. Within the portfolio there are enzymes specific for: IgG digestion - FabRICATORTM, FabALACTICATM, GingisKHANTM, FabULOUSTM & FabRICATOR … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | 43 | |
Orexo AB publ Improves lives for patients suffering from mental illness and substance use disorder 💚 Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2022 amounted to SEK 624 million, and the number of employees to 126. Orexo is listed on Nasdaq Stockholm's main list and is available as an … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 6 | 1 | 3 | 107 | |
Medicines for Malaria Venture Ending malaria, rewriting the future MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Our vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease. Our success in research and access & product management comes from our extensive partnership network of over 375 pharmaceutical, academic and endemic-country partners in 50 countries. www.mmv.org www.facebook.com/medicinesformalaria www.twitter.com/medsformalaria www.youtube.com/user/MMVmeds4malaria http://plus.google.com/+mmvorgmedsformalaria Research and Development, Product Development Partnership (PDP), Medicines, and Malaria Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 13 | 4 | 8 | 159 | |
Symphogen Symphogen A/S, a Servier company and the Centre of Excellence for Antibodies, operates within in research, early clinical stages and CMC biologics development from research to market. Supporting Servier’s commitment to improve patients health and the R&D strategy within oncology and immune-oncology - Symphogen’s strategic focus is to apply our streamlined and effective antibody platform and capabilities in the discovery and early development of highly differentiated antibodies. The aim is to develop novel compounds either as combination or as stand-alone therapies for difficult to treat cancers. oncology, immune-evasive, and AXL Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 195 | |
Medisafe, a STERIS Company Medisafe is now STERIS Medisafe is now STERIS. Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
CADTH Canada’s Drug and Health Technology Agency. As of May 1, 2024, CADTH is now Canada's Drug Agency. Please follow our new LinkedIn page at linkedin.com/company/cda-amc, as this page will no longer be updated or monitored. Health research, Health technology assessment, Economic evaluation of health technologies, Knowledge mobilization, Cost-effectiveness analysis, Critical appraisal, Network meta-analysis, Systematic reviews, and Patient engagement Type: SMB Activities: healthtech Technologies: Synthetic Biology | 5 | 1 | 4 | 125 | |
Radius Health, Inc. We are a biopharmaceutical company dedicated?to transforming the future for underserved, global patient populations in bone health and related areas. We consistently embrace opportunities to improve the lives of our patients, their caregivers, our communities, our partners, and each other. Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 3 | 0 | 1 | 312 | |
PsychoGenics Discover Your Next Breakthrough PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next generation of treatments for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development. We are known for our cutting-edge translational approach to research, our customized solutions, the breadth and quality of our work, as well as for our ability to identify statistically relevant phenotypic changes that help our clients quantify the efficacy of their treatments before they move into … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 149 |